ILT11/LILRA5 Antibody (018) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90323DL594
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 018
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ILT11/LILRA5 Antibody (018) [DyLight 594]
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human ILT11/LILRA5 (Accession#: NP_067073.1; Met1-Arg268).
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for ILT11/LILRA5 Antibody (018) [DyLight 594]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LILRA5/CD85f
Long Name
Leukocyte Immunoglobulin-like Receptor Subfamily A Member 5
Alternate Names
CD85f, ILT11, LILRB7, LIR9
Gene Symbol
LILRA5
Additional LILRA5/CD85f Products
Product Documents for ILT11/LILRA5 Antibody (018) [DyLight 594]
Product Specific Notices for ILT11/LILRA5 Antibody (018) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...